drugset / Trial / NCT00376662

HRT Versus Etidronate for Osteoporosis and Fractures in Asthmatics Receiving Glucocorticoids.

NCT00376662

Phase 4 Completed 750 enrolled British Thoracic Society
RandomizedFactorialOpen-labelTreatment

Summary

To determine and compare the effects of Hormone replacement therapy (HRT), etidronate, HRT plus etidronate and no treatment over 5 years in the prevention and treatment of glucocorticoid-induced osteoporosis and fractures in post-menopausal women with asthma.

Timeline

Start
1992-08
Primary completion
Completion
2000-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Etidronate Small molecule

Indications